- Home
- PWR vs ZTS Comparison
PWR vs ZTS Comparison
Compare PWR & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWR
- ZTS
- Stock Information
- Founded
- PWR 1997
- ZTS 1952
- Country
- PWR United States
- ZTS United States
- Employees
- PWR N/A
- ZTS N/A
- Industry
- PWR Engineering & Construction
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- PWR Industrials
- ZTS Health Care
- Exchange
- PWR Nasdaq
- ZTS Nasdaq
- Market Cap
- PWR 55.4B
- ZTS 66.3B
- IPO Year
- PWR 1998
- ZTS 2013
- Fundamental
- Price
- PWR $394.83
- ZTS $147.40
- Analyst Decision
- PWR Buy
- ZTS Buy
- Analyst Count
- PWR 22
- ZTS 8
- Target Price
- PWR $374.16
- ZTS $204.00
- AVG Volume (30 Days)
- PWR 1.2M
- ZTS 3.3M
- Earning Date
- PWR 07-31-2025
- ZTS 08-05-2025
- Dividend Yield
- PWR 0.10%
- ZTS 1.36%
- EPS Growth
- PWR 21.63
- ZTS 7.32
- EPS
- PWR 6.44
- ZTS 5.57
- Revenue
- PWR $26,052,930,000.00
- ZTS $9,286,000,000.00
- Revenue This Year
- PWR $15.24
- ZTS $3.63
- Revenue Next Year
- PWR $9.53
- ZTS $6.13
- P/E Ratio
- PWR $61.34
- ZTS $26.46
- Revenue Growth
- PWR 18.26
- ZTS 6.32
- 52 Week Low
- PWR $227.08
- ZTS $139.70
- 52 Week High
- PWR $424.94
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- PWR 52.34
- ZTS 36.45
- Support Level
- PWR $408.33
- ZTS $148.54
- Resistance Level
- PWR $423.50
- ZTS $152.30
- Average True Range (ATR)
- PWR 10.41
- ZTS 2.92
- MACD
- PWR -1.39
- ZTS -0.26
- Stochastic Oscillator
- PWR 32.08
- ZTS 19.97
About PWR Quanta Services Inc.
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two segments: electric infrastructure and underground utility and infrastructure.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.